IMMUNOBIOLOGICAL ASPECTS OF PSORIASIS PATHOGENESIS
Keywords:
Keywords: To summarize current scientific data on the immunobiological mechanisms underlying psoriasis development, focusing on the interplay between innate and adaptive immune cells, the role of pro-inflammatory cytokines, and the mechanisms sustaining chronic inflammation.Abstract
Psoriasis is a chronic, immune-mediated inflammatory skin disease characterized by disrupted keratinocyte proliferation and differentiation, activation of innate and adaptive immunity, and the establishment of a persistent inflammatory process. Current research highlights the pivotal role of the interleukin-23 (IL-23)/interleukin-17 (IL-17) immune axis in the disease's pathogenesis. Investigating the molecular and cellular mechanisms of psoriasis is crucial for understanding its chronic, relapsing course and for developing targeted therapies.
References
1.Sieminska, M., & others. (2024). Immunopathogenesis of psoriasis and the role of the IL-23/IL-17 axis. International Journal of Molecular Sciences.
2.Kamata, M., & Tada, Y. (2023). Current understanding of the molecular mechanisms of psoriasis. International Journal of Molecular Sciences.
3.Deng, G., Zhang, Y., Song, J., Zhang, Y., Zheng, Q., Luo, Y., Fei, X., Yang, Y., Kuai, L., Li, B., & Luo, Y. (2024). The role and therapeutic strategies for tissue-resident memory T cells, central memory T cells, and effector memory T cells in psoriasis. Immunology, 173(3), 470–480. https://doi.org/10.1111/imm.13843 PubMed
4.Kim, J., & Krueger, J. G. (2017). Highly effective new treatments for psoriasis target the IL-23/IL-17 axis. Annual Review of Medicine, 68, 255–269.
5.Hawkes, J. E., Chan, T. C., & Krueger, J. G. (2017). Psoriasis pathogenesis and the development of novel targeted immune therapies. Journal of Allergy and Clinical Immunology, 140(3), 645–653.